Linifanib (ABT-869) - CAS# 796967-16-3 Size:10mg solid PMID: 32658637

PMID: 32658637

Methanol (Slightly)

ERRα overexpression further aggravates PAN-induced apoptosis

Achyrodimer F

Ketanserin depresses and in certain experiments reverses the vasoconstrictor response to 5-hydroxytryptamine in the perfused guinea-pig stomach

Linifanib (ABT-869) - CAS# 796967-16-3 Size:10mg solid PMID: 32658637Linifanib, CAS No. 796967 16 3, also known as ABT 869, is an orally bioavailable, small molecule receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic activity. Linifanib inhibits members of the vascular endothelial growth factor (VEGF) and platelet derived growth factor (PDGF) receptor families; it exhibits much less activity against unrelated RTKs, soluble tyrosine kinases, or serine threonine kinases. This agent does not have a